Ethyl 5-bromo-1,4-dimethyl-1H-pyrazole-3-carboxylate, 95%, 1g

methyl 2-ethoxy-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate, 97%, 100g

2-(6-(Benzyloxy)-3-nitropyridin-2-yl)acetonitrile, 95%, 500mg

1,4-Difluorobenzene, 99.0%, 1kg

2-((4-(Pyridin-2-yl)piperazin-1-yl)methyl)-1H-benzo[d]imidazole trihydrochloride, 97.0%, 100mg

N-(2,4-dimethoxybenzyl)-2-oxo-N-(1,2,4-thiadiazol-5-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 95%, 10g

4,5-Dichloro-2H-pyridazin-3-one, 97.0%, 10g

Z-Ser-Ome, 95%, 500g

1-(2,4-DIFLUOROPHENYL)-N-METHYLMETHANAMINE HCL, 97.0%, 5g

1-(Piperidin-4-yl)ethanone, 95+%, 1g

Siliconöl M 5, stabilisiert, niedrigviskos, 5 cSt, 5 l, Kunst.

Quinoxaline-5-sulfonyl chloride, 95.0%, 250mg

7-Bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine, 98%, 250mg